Liquid biopsy to diagnose EGFR T790M mutation in previously radiated non-small-cell lung cancer brain metastases and rapid response to osimertinib

被引：0
|
作者：
Matzdorff, A. [1 ]
Meier, A. [1 ]
Lenze, D. [2 ]
Hartmann, J. [3 ]
Pielsticker, C. [3 ]
Gawliczek, A. [1 ]
机构：
[1] Asklepios Klinikum Uckermark, Med Klin 2, Schwedt, Germany
[2] Charite Univ Med Berlin, Inst Pathol, Berlin, Germany
[3] Asklepios Klinikum Uckermark, Inst Radiol, Schwedt, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2017年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P815
引用
收藏
页码：231 / 231
页数：1
相关论文
共 50 条
  • [21] Utility of T790M plasma and tissue biopsy testing in EGFR mutated non-small-cell lung cancer patients
    Preda, E.
    Shamash, J.
    Tarver, K.
    Ball, S.
    LUNG CANCER, 2020, 139 : S61 - S62
  • [22] Detection of EGFR T790M mutation in non-small-cell lung cancer patients using colony hybridization assay
    Fujita, Yoshihiko
    Suda, Kenichi
    Kimura, Hideharu
    Matsumoto, Kazuko
    Arao, Tokuzo
    Nagai, Tomoyuki
    Hayashi, Hidetoshi
    Furuta, Kazuyuki
    Kato, Hiroaki
    Saijo, Nagahiro
    Yatabe, Yasushi
    Mitsudomi, Tetsuya
    Nishio, Kazuto
    CANCER RESEARCH, 2012, 72
  • [23] EGFR T790M Mutation Detection and Osimertinib Treatment Response Evaluation by Liquid Biopsy in Advanced NSCLC Patients
    Li, C.
    Liu, H.
    Zhang, B.
    Zhang, Z.
    Su, Y.
    Wang, C.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2141 - S2142
  • [24] EGFR T790M relative mutation purity predicts osimertinib treatment efficacy in non-small cell lung cancer patients
    Zheng, Qiufan
    Hong, Shaodong
    Huang, Yan
    Zhao, Hongyun
    Yang, Yunpeng
    Hou, Xue
    Zhao, Yuanyuan
    Ma, Yuxiang
    Zhou, Ting
    Zhang, Yaxiong
    Fang, Wenfeng
    Zhang, Li
    CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 9 (01):
  • [25] Sequential treatment of afatinib followed by osimertinib in T790M EGFR mutation positive non-small-cell lung cancer (NSCLC) pa tients: an observational study
    Hochmair, M.
    Morabito, A.
    Hao, D.
    Yang, C. -T.
    Soo, R. A.
    Gucalp, R.
    Halmos, B.
    Wang, L.
    Golembesky, A.
    Maerten, A.
    Cufer, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 75 - 75
  • [26] EGFR T790M resistance mutation in non small-cell lung carcinoma
    Denis, Marc G.
    Vallee, Audrey
    Theoleyre, Sandrine
    CLINICA CHIMICA ACTA, 2015, 444 : 81 - 85
  • [27] Response to osimertinib in a colorectal cancer patient with an EGFR T790M mutation: A case report
    Buzard, Blake
    Douglass, Lindsey
    Gustafson, Beth
    Buckley, Jennifer
    Roth, Marc
    Kujtan, Lara
    Bansal, Dhruv
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 15 (10) : 1829 - 1834
  • [28] Spatiotemporal T790M Heterogeneity in a Patient with EGFR-Mutant Non-Small-Cell Lung Cancer
    Hata, Akito
    Masago, Katsuhiro
    Katakami, Nobuyuki
    Imai, Yukihiro
    Yatabe, Yasushi
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (08) : E64 - E65
  • [29] Favorable Conditions for the Detection of EGFR T790M Mutation Using Plasma Sample in Patients with Non-Small-Cell Lung Cancer
    Kim, Insu
    Seol, Hee Yun
    Kim, Soo Han
    Kim, Mi-Hyun
    Lee, Min Ki
    Eom, Jung Seop
    CANCERS, 2023, 15 (05)
  • [30] Clinical Factors Predicting Detection of T790M Mutation in Rebiopsy for EGFR-Mutant Non-small-cell Lung Cancer
    Kawamura, Takahisa
    Kenmotsu, Hirotsugu
    Omori, Shota
    Nakashima, Kazuhisa
    Wakuda, Kazushige
    Ono, Akira
    Naito, Tateaki
    Murakami, Haruyasu
    Omae, Katsuhiro
    Mori, Keita
    Tanigawara, Yusuke
    Nakajima, Takashi
    Ohde, Yasuhisa
    Endo, Masahiro
    Takahashi, Toshiaki
    CLINICAL LUNG CANCER, 2018, 19 (02) : E247 - E252
12345